asa glp 1 agonist guidelines Glucagon-Like Peptide-1 Receptor Agonists–Health Professional Version New Year, New Bod? Words

Evidence is emerging that glucagon-like peptide-1 (GLP-1) receptor agonists have anti-inflammatory and chondroprotective properties independent of their effects on weight loss

CU Cancer Center member Bryan Haugen, MD, breaks down the science behind the FDA warning on the GLP-1 weight-loss medications.

While effective, these treatments require monitoring due to potential side effects, especially in non-diabetic patients.This therapeutic advancement represents a revolution in the management of metabolic diseases and obesity.Despite their efficacy in managing obesity and metabolic disorders, GLP-1 and GIP receptor agonists can cause side effects, which are a common reason for therapy discontinuation

As an Integrative and Functional Nutrition Health Coach, I want to provide a balanced discussion on this topic.

Recent studies have highlighted the effectiveness ofweight loss medications, particularly GLP-1 agonists like Semaglutide (found in Wegovy and Ozempic) and Tirzepatide (found []

Better Regularity: Supports healthy, regular bathroom habits and overall bowel health